View Future GrowthPathkey.AI 과거 순이익 실적과거 기준 점검 0/6Pathkey.AI 의 수입은 연평균 -10.3%의 비율로 감소해 온 반면, Software 산업은 연평균 14.6%의 비율로 증가했습니다. 매출은 연평균 9.9%의 비율로 감소해 왔습니다.핵심 정보-10.29%순이익 성장률21.37%주당순이익(EPS) 성장률Software 산업 성장률22.05%매출 성장률-9.88%자기자본이익률-274.41%순이익률-496.70%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Aug 31Full year 2025 earnings released: AU$0.008 loss per share (vs AU$0.018 loss in FY 2024)Full year 2025 results: AU$0.008 loss per share (improved from AU$0.018 loss in FY 2024). Net loss: AU$1.45m (loss narrowed 54% from FY 2024). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 31Full year 2024 earnings released: AU$0.018 loss per share (vs AU$0.022 loss in FY 2023)Full year 2024 results: AU$0.018 loss per share. Revenue: AU$932.1k (up 51% from FY 2023). Net loss: AU$3.13m (loss widened 81% from FY 2023).공시 • Aug 24+ 1 more updateOpyl Limited to Report Fiscal Year 2023 Results on Aug 30, 2023Opyl Limited announced that they will report fiscal year 2023 results on Aug 30, 2023모든 업데이트 보기Recent updatesBoard Change • May 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Director Shannon Robinson was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • May 01No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Director Shannon Robinson was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Feb 04Pathkey.AI Ltd has completed a Follow-on Equity Offering in the amount of AUD 2.262595 million.Pathkey.AI Ltd has completed a Follow-on Equity Offering in the amount of AUD 2.262595 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 188,549,547 Price\Range: AUD 0.012 Discount Per Security: AUD 0.00072 Transaction Features: Subsequent Direct Listing공시 • Jan 07Pathkey.AI Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.335776 million.Pathkey.AI Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.335776 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 27,981,343 Price\Range: AUD 0.012 Discount Per Security: AUD 0.00072 Transaction Features: Rights OfferingBoard Change • Dec 31No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 5 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Member of Advisory Board Kirsten Daru is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.공시 • Dec 17Pathkey.AI Ltd has filed a Follow-on Equity Offering in the amount of AUD 2.262595 million.Pathkey.AI Ltd has filed a Follow-on Equity Offering in the amount of AUD 2.262595 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 188,549,547 Price\Range: AUD 0.012 Discount Per Security: AUD 0.00072 Transaction Features: Subsequent Direct Listing공시 • Nov 27Pathkey.AI Ltd has completed a Follow-on Equity Offering in the amount of AUD 2.5 million.Pathkey.AI Ltd has completed a Follow-on Equity Offering in the amount of AUD 2.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 19,783,786 Price\Range: AUD 0.012 Discount Per Security: AUD 0.00072 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 188,549,547 Price\Range: AUD 0.012 Discount Per Security: AUD 0.00072 Transaction Features: Subsequent Direct Listing공시 • Oct 02Pathkey.AI Ltd, Annual General Meeting, Nov 26, 2025Pathkey.AI Ltd, Annual General Meeting, Nov 26, 2025.New Risk • Aug 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$1.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.3m free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Negative equity (-AU$268k). Earnings have declined by 20% per year over the past 5 years. Shareholders have been substantially diluted in the past year (73% increase in shares outstanding). Revenue is less than US$1m (AU$322k revenue, or US$211k). Market cap is less than US$10m (AU$7.10m market cap, or US$4.65m).Reported Earnings • Aug 31Full year 2025 earnings released: AU$0.008 loss per share (vs AU$0.018 loss in FY 2024)Full year 2025 results: AU$0.008 loss per share (improved from AU$0.018 loss in FY 2024). Net loss: AU$1.45m (loss narrowed 54% from FY 2024). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.Board Change • Aug 18No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 5 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Member of Advisory Board Kirsten Daru is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.공시 • May 02Opyl Limited has completed a Follow-on Equity Offering in the amount of AUD 1.5 million.Opyl Limited has completed a Follow-on Equity Offering in the amount of AUD 1.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 42,000,000 Price\Range: AUD 0.021 Discount Per Security: AUD 0.00126 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 29,428,572 Price\Range: AUD 0.021 Discount Per Security: AUD 0.00126 Security Features: Attached Options Transaction Features: Subsequent Direct Listing공시 • Oct 11Opyl Limited, Annual General Meeting, Nov 21, 2024Opyl Limited, Annual General Meeting, Nov 21, 2024.공시 • Sep 05Opyl Limited Announces Company Secretary ChangesOpyl Limited announced the appointment of Mr. Jonathan Hart as the new Company Secretary, effective immediately. Mr. Hart has 20+ years of corporate advisory experience. He has extensive cross border experience specializing in corporate advisory, scale up and debt and equity financing, across a broad range of industry sectors. Mr. Hart holds a Bachelor of Laws and Commerce and currently serves as a director of Hartness Consulting Pty Ltd, established in 2012 specializing in corporate advisory and equity services to private and publicly listed companies in a range of sectors including technology, healthcare and resources. His extensive experience and deep understanding of corporate governance, compliance, and strategic advisory will be instrumental as Opyl continues to execute its strategic initiatives. The Board takes this opportunity to thank Mr. David Lilja of DLK Advisory for his invaluable contributions to the Company as the outgoing Company Secretary.Reported Earnings • Aug 31Full year 2024 earnings released: AU$0.018 loss per share (vs AU$0.022 loss in FY 2023)Full year 2024 results: AU$0.018 loss per share. Revenue: AU$932.1k (up 51% from FY 2023). Net loss: AU$3.13m (loss widened 81% from FY 2023).공시 • Aug 23Opyl Limited announced that it has received AUD 0.7 million in fundingOpyl Limited announced that it has received AUD 700,000 through short-term loan agreements in funding on August 22, 2024. The transaction includes participation from new lenders Peak Asset Management LLC, Irwin Biotech Nominees Pty Ltd, Rip Opportunities Pty Ltd and Antanas "Tony" Guoga.공시 • Apr 30Opyl Limited, Annual General Meeting, May 27, 2024Opyl Limited, Annual General Meeting, May 27, 2024, at 15:00 E. Australia Standard Time. Agenda: To consider approval of disposal of OPIN business; to election of executive-director Mr. Saurabh Jain; to approval of issue of shares to Mr. Mark Ziirsen conversion of director fees outstanding; to approval of issue of shares to Mr. Damon Rasheed conversion of director fees outstanding; to approval of issue of shares to Mr. Antanas Guoga conversion of director fees outstanding; to approval to issue of 10,000,000 lead manager options; to ratification of prior issue of 19,200,000 placement shares; to ratification of prior issue of 429,185 shares; and to consider other matters if any.Board Change • Mar 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Mark Simari was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Feb 06No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Mark Simari was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Jan 17Opyl Limited has completed a Follow-on Equity Offering in the amount of AUD 0.687158 million.Opyl Limited has completed a Follow-on Equity Offering in the amount of AUD 0.687158 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 22,905,260 Price\Range: AUD 0.03 Discount Per Security: AUD 0.0018 Transaction Features: Rights OfferingBoard Change • Jan 12No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Mark Simari was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Dec 14+ 1 more updateOpyl Limited has completed a Follow-on Equity Offering in the amount of AUD 0.576 million.Opyl Limited has completed a Follow-on Equity Offering in the amount of AUD 0.576 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 19,199,995 Price\Range: AUD 0.03 Discount Per Security: AUD 0.0018 Transaction Features: Subsequent Direct Listing공시 • Nov 24Opyl Limited Appoints Saurabh Jain as Interim Chief Executive OfficerOpyl Limited announced the appointment of Mr. Saurabh Jain as interim Chief Executive Officer of Opyl, effective 24 November 2023. Saurabh is tasked with overseeing and driving the launch of Opyl's new predictive analytics and insights platform, TrialKey, and continuing to support the Opin business as it executes on its new go-to-market strategy. Saurabh is an accomplished technology entrepreneur with a track record of commercialising, scaling and transitioning management to proven leadership in emerging technology businesses. In 1997, he founded Netpro Express, an internet service provider that was later acquired by Telstra. Since then, Saurabh has held various senior executive roles at Ventia, Cushman Wakefield and was previously CEO and Executive Director of Urbanise. Most recently, Saurabh joined the Spacetalk board where he stepped into the role of acting CEO before transitioning to the current leadership, at which point he stepped back into his prior role as Non-Executive Director. Saurabh brings over 25 years of experience across both ASX boards and private companies, leveraging his entrepreneurial and commercial acumen, a history of deep technical expertise and oversight over transformative organisational change. His experience will be critical in accelerating the commercialisation of TrialKey, overseeing the growth of Opin, and driving equity value uplift across the business. Saurabh holds a Bachelor of Engineering (Software Engineering), an Executive Master of Business Administration and a Master of Business Technology from the Australian Graduate School of Management, UNSW.Board Change • Nov 07No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Mark Simari was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Oct 31Opyl Limited, Annual General Meeting, Nov 29, 2023Opyl Limited, Annual General Meeting, Nov 29, 2023, at 15:00 AUS Eastern Standard Time. Location: Engine House, 105 Wellington Street Saint Kilda Victoria Australia Agenda: To receive the Financial Statements, Director's Report and Auditor's Report for the Company for the year ended 30 June 2023; to consider and approve the remuneration report; to consider and approve the election of Director; to consider and approve to issue of incentive options; to consider and approve the conversion of Director fees; to consider and approve to issue loan options; and to consider and approve the 10% placement capacity.공시 • Aug 24+ 1 more updateOpyl Limited to Report Fiscal Year 2023 Results on Aug 30, 2023Opyl Limited announced that they will report fiscal year 2023 results on Aug 30, 2023New Risk • Jul 10New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$886k free cash flow). Shares are highly illiquid. Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Revenue is less than US$1m (AU$901k revenue, or US$603k). Market cap is less than US$10m (AU$3.66m market cap, or US$2.45m).공시 • Jul 06+ 1 more updateOpyl Limited Announces Senior Leadership ChangesOpyl Limited announced changes to its senior leadership with Dr Hugo Stephenson joining to lead Opin, Michelle Gallaher moving to General Manager of TrialKey and Mark Ziirsen stepping in as the Executive Chairman. These changes follow the Board-led strategic review focused on identifying pathways for accelerating the growth of Opin and developing pathways to commercialise TrialKey. To better support and drive its strategic priorities, the Board announced a realignment of internal resources. As a result, Michelle Gallaher has permanently stepped down as CEO of Opyl Limited, with immediate effect, and will transition to the role of GM TrialKey for a specified period. In her new role, Michelle will work alongside Executive Director and CTO, Damon Rasheed, on further development of the TrialKey platform. The Board is delighted to announce that following his recent appointment as Strategic Advisor to the Board, Dr Hugo Stephenson has agreed to join the company to lead Opin, the company's clinical trial recruitment business. In this role, Dr Stephenson will specifically focus on: Accelerating recruitment for ANZ-based clinical trials and health programs; Streamlining Opin's business model to align with ANZ client needs; Unlocking new business opportunities in patient community growth and management; Broadening Asia Pacific partnerships with research sites, healthcare institutions and advocacy groups; Pursuing M&A opportunities in the Asia Pacific region; and Cultivating global growth opportunities. For the near term, Mr. Mark Ziirsen, Executive Chair will assume expanded executive duties, spending more time in the Melbourne head office, to provide support for these management changes.Board Change • Jun 28No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 6 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Member of Advisory Board Kirsten Daru is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.Board Change • Jun 05No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 6 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Member of Advisory Board Kirsten Daru is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.공시 • May 04Opyl Limited Appoints Dr. Hugo Stephenson as Board AdvisorOpyl Limited announced that it has engaged leading global clinical trial expert and eminent business leader in the health technology sector, Dr. Hugo Stephenson, as an advisor to the board. His appointment is an important development in the Company's strategic review, which focuses on accelerating the growth of Opin and monetising the TrialKey technology platform. Dr. Stephenson is a medical doctor, technologist, biotech services entrepreneur and founder of a number of successful businesses in the international clinical trials industry, including: DrugDev, a leading provider of e-clinical technologies and clinical trial payment services; MediGuard, the largest online medication monitoring service; Health Research Solutions (HRS), a late phase contract research organisation; and MedSeed, a pioneer of hospital and GP decision support software. Dr. Stephenson worked for many years as the founder of Quintiles' global late phase research division (now IQVIA) following the acquisition of HRS, and has considerable experience managing organisations within both a public market and private equity-backed environment. He is also the founder and past Chief Executive Officer of the Induction Healthcare Group PLC.Board Change • May 02No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Megan Robertson was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.매출 및 비용 세부 내역Pathkey.AI가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이CHIA:PKY 매출, 비용 및 순이익 (AUD Millions)날짜매출순이익일반관리비연구개발비31 Dec 250-11030 Sep 250-11030 Jun 250-11031 Mar 251-21031 Dec 241-32030 Sep 241-32030 Jun 241-32031 Mar 241-32031 Dec 231-21030 Sep 231-21030 Jun 231-21031 Mar 231-11031 Dec 221-11030 Sep 221-21130 Jun 221-21131 Mar 221-21031 Dec 211-31030 Sep 211-21030 Jun 211-11031 Mar 211-11031 Dec 20101030 Sep 20101030 Jun 201-11031 Mar 201-21031 Dec 191-31030 Sep 191-31030 Jun 191-32031 Mar 191-32031 Dec 181-32030 Sep 181-32030 Jun 180-32031 Mar 180-32031 Dec 170-32030 Sep 170-32030 Jun 170-32031 Mar 170-52031 Dec 160-72030 Sep 160-72030 Jun 160-61030 Jun 150-100양질의 수익: PKY 은(는) 현재 수익성이 없습니다.이익 마진 증가: PKY는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: PKY은 수익성이 없으며 지난 5년 동안 손실이 연평균 10.3% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 PKY의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: PKY은 수익성이 없어 지난 해 수익 성장률을 Software 업계(10.5%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: PKY는 현재 수익성이 없으므로 자본 수익률이 음수(-274.41%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YSoftware 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/27 12:13종가2026/05/27 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Pathkey.AI Ltd는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Aug 31Full year 2025 earnings released: AU$0.008 loss per share (vs AU$0.018 loss in FY 2024)Full year 2025 results: AU$0.008 loss per share (improved from AU$0.018 loss in FY 2024). Net loss: AU$1.45m (loss narrowed 54% from FY 2024). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 31Full year 2024 earnings released: AU$0.018 loss per share (vs AU$0.022 loss in FY 2023)Full year 2024 results: AU$0.018 loss per share. Revenue: AU$932.1k (up 51% from FY 2023). Net loss: AU$3.13m (loss widened 81% from FY 2023).
공시 • Aug 24+ 1 more updateOpyl Limited to Report Fiscal Year 2023 Results on Aug 30, 2023Opyl Limited announced that they will report fiscal year 2023 results on Aug 30, 2023
Board Change • May 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Director Shannon Robinson was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • May 01No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Director Shannon Robinson was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Feb 04Pathkey.AI Ltd has completed a Follow-on Equity Offering in the amount of AUD 2.262595 million.Pathkey.AI Ltd has completed a Follow-on Equity Offering in the amount of AUD 2.262595 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 188,549,547 Price\Range: AUD 0.012 Discount Per Security: AUD 0.00072 Transaction Features: Subsequent Direct Listing
공시 • Jan 07Pathkey.AI Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.335776 million.Pathkey.AI Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.335776 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 27,981,343 Price\Range: AUD 0.012 Discount Per Security: AUD 0.00072 Transaction Features: Rights Offering
Board Change • Dec 31No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 5 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Member of Advisory Board Kirsten Daru is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
공시 • Dec 17Pathkey.AI Ltd has filed a Follow-on Equity Offering in the amount of AUD 2.262595 million.Pathkey.AI Ltd has filed a Follow-on Equity Offering in the amount of AUD 2.262595 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 188,549,547 Price\Range: AUD 0.012 Discount Per Security: AUD 0.00072 Transaction Features: Subsequent Direct Listing
공시 • Nov 27Pathkey.AI Ltd has completed a Follow-on Equity Offering in the amount of AUD 2.5 million.Pathkey.AI Ltd has completed a Follow-on Equity Offering in the amount of AUD 2.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 19,783,786 Price\Range: AUD 0.012 Discount Per Security: AUD 0.00072 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 188,549,547 Price\Range: AUD 0.012 Discount Per Security: AUD 0.00072 Transaction Features: Subsequent Direct Listing
공시 • Oct 02Pathkey.AI Ltd, Annual General Meeting, Nov 26, 2025Pathkey.AI Ltd, Annual General Meeting, Nov 26, 2025.
New Risk • Aug 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$1.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.3m free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Negative equity (-AU$268k). Earnings have declined by 20% per year over the past 5 years. Shareholders have been substantially diluted in the past year (73% increase in shares outstanding). Revenue is less than US$1m (AU$322k revenue, or US$211k). Market cap is less than US$10m (AU$7.10m market cap, or US$4.65m).
Reported Earnings • Aug 31Full year 2025 earnings released: AU$0.008 loss per share (vs AU$0.018 loss in FY 2024)Full year 2025 results: AU$0.008 loss per share (improved from AU$0.018 loss in FY 2024). Net loss: AU$1.45m (loss narrowed 54% from FY 2024). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.
Board Change • Aug 18No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 5 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Member of Advisory Board Kirsten Daru is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
공시 • May 02Opyl Limited has completed a Follow-on Equity Offering in the amount of AUD 1.5 million.Opyl Limited has completed a Follow-on Equity Offering in the amount of AUD 1.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 42,000,000 Price\Range: AUD 0.021 Discount Per Security: AUD 0.00126 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 29,428,572 Price\Range: AUD 0.021 Discount Per Security: AUD 0.00126 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
공시 • Oct 11Opyl Limited, Annual General Meeting, Nov 21, 2024Opyl Limited, Annual General Meeting, Nov 21, 2024.
공시 • Sep 05Opyl Limited Announces Company Secretary ChangesOpyl Limited announced the appointment of Mr. Jonathan Hart as the new Company Secretary, effective immediately. Mr. Hart has 20+ years of corporate advisory experience. He has extensive cross border experience specializing in corporate advisory, scale up and debt and equity financing, across a broad range of industry sectors. Mr. Hart holds a Bachelor of Laws and Commerce and currently serves as a director of Hartness Consulting Pty Ltd, established in 2012 specializing in corporate advisory and equity services to private and publicly listed companies in a range of sectors including technology, healthcare and resources. His extensive experience and deep understanding of corporate governance, compliance, and strategic advisory will be instrumental as Opyl continues to execute its strategic initiatives. The Board takes this opportunity to thank Mr. David Lilja of DLK Advisory for his invaluable contributions to the Company as the outgoing Company Secretary.
Reported Earnings • Aug 31Full year 2024 earnings released: AU$0.018 loss per share (vs AU$0.022 loss in FY 2023)Full year 2024 results: AU$0.018 loss per share. Revenue: AU$932.1k (up 51% from FY 2023). Net loss: AU$3.13m (loss widened 81% from FY 2023).
공시 • Aug 23Opyl Limited announced that it has received AUD 0.7 million in fundingOpyl Limited announced that it has received AUD 700,000 through short-term loan agreements in funding on August 22, 2024. The transaction includes participation from new lenders Peak Asset Management LLC, Irwin Biotech Nominees Pty Ltd, Rip Opportunities Pty Ltd and Antanas "Tony" Guoga.
공시 • Apr 30Opyl Limited, Annual General Meeting, May 27, 2024Opyl Limited, Annual General Meeting, May 27, 2024, at 15:00 E. Australia Standard Time. Agenda: To consider approval of disposal of OPIN business; to election of executive-director Mr. Saurabh Jain; to approval of issue of shares to Mr. Mark Ziirsen conversion of director fees outstanding; to approval of issue of shares to Mr. Damon Rasheed conversion of director fees outstanding; to approval of issue of shares to Mr. Antanas Guoga conversion of director fees outstanding; to approval to issue of 10,000,000 lead manager options; to ratification of prior issue of 19,200,000 placement shares; to ratification of prior issue of 429,185 shares; and to consider other matters if any.
Board Change • Mar 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Mark Simari was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Feb 06No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Mark Simari was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Jan 17Opyl Limited has completed a Follow-on Equity Offering in the amount of AUD 0.687158 million.Opyl Limited has completed a Follow-on Equity Offering in the amount of AUD 0.687158 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 22,905,260 Price\Range: AUD 0.03 Discount Per Security: AUD 0.0018 Transaction Features: Rights Offering
Board Change • Jan 12No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Mark Simari was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Dec 14+ 1 more updateOpyl Limited has completed a Follow-on Equity Offering in the amount of AUD 0.576 million.Opyl Limited has completed a Follow-on Equity Offering in the amount of AUD 0.576 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 19,199,995 Price\Range: AUD 0.03 Discount Per Security: AUD 0.0018 Transaction Features: Subsequent Direct Listing
공시 • Nov 24Opyl Limited Appoints Saurabh Jain as Interim Chief Executive OfficerOpyl Limited announced the appointment of Mr. Saurabh Jain as interim Chief Executive Officer of Opyl, effective 24 November 2023. Saurabh is tasked with overseeing and driving the launch of Opyl's new predictive analytics and insights platform, TrialKey, and continuing to support the Opin business as it executes on its new go-to-market strategy. Saurabh is an accomplished technology entrepreneur with a track record of commercialising, scaling and transitioning management to proven leadership in emerging technology businesses. In 1997, he founded Netpro Express, an internet service provider that was later acquired by Telstra. Since then, Saurabh has held various senior executive roles at Ventia, Cushman Wakefield and was previously CEO and Executive Director of Urbanise. Most recently, Saurabh joined the Spacetalk board where he stepped into the role of acting CEO before transitioning to the current leadership, at which point he stepped back into his prior role as Non-Executive Director. Saurabh brings over 25 years of experience across both ASX boards and private companies, leveraging his entrepreneurial and commercial acumen, a history of deep technical expertise and oversight over transformative organisational change. His experience will be critical in accelerating the commercialisation of TrialKey, overseeing the growth of Opin, and driving equity value uplift across the business. Saurabh holds a Bachelor of Engineering (Software Engineering), an Executive Master of Business Administration and a Master of Business Technology from the Australian Graduate School of Management, UNSW.
Board Change • Nov 07No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Mark Simari was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Oct 31Opyl Limited, Annual General Meeting, Nov 29, 2023Opyl Limited, Annual General Meeting, Nov 29, 2023, at 15:00 AUS Eastern Standard Time. Location: Engine House, 105 Wellington Street Saint Kilda Victoria Australia Agenda: To receive the Financial Statements, Director's Report and Auditor's Report for the Company for the year ended 30 June 2023; to consider and approve the remuneration report; to consider and approve the election of Director; to consider and approve to issue of incentive options; to consider and approve the conversion of Director fees; to consider and approve to issue loan options; and to consider and approve the 10% placement capacity.
공시 • Aug 24+ 1 more updateOpyl Limited to Report Fiscal Year 2023 Results on Aug 30, 2023Opyl Limited announced that they will report fiscal year 2023 results on Aug 30, 2023
New Risk • Jul 10New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$886k free cash flow). Shares are highly illiquid. Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Revenue is less than US$1m (AU$901k revenue, or US$603k). Market cap is less than US$10m (AU$3.66m market cap, or US$2.45m).
공시 • Jul 06+ 1 more updateOpyl Limited Announces Senior Leadership ChangesOpyl Limited announced changes to its senior leadership with Dr Hugo Stephenson joining to lead Opin, Michelle Gallaher moving to General Manager of TrialKey and Mark Ziirsen stepping in as the Executive Chairman. These changes follow the Board-led strategic review focused on identifying pathways for accelerating the growth of Opin and developing pathways to commercialise TrialKey. To better support and drive its strategic priorities, the Board announced a realignment of internal resources. As a result, Michelle Gallaher has permanently stepped down as CEO of Opyl Limited, with immediate effect, and will transition to the role of GM TrialKey for a specified period. In her new role, Michelle will work alongside Executive Director and CTO, Damon Rasheed, on further development of the TrialKey platform. The Board is delighted to announce that following his recent appointment as Strategic Advisor to the Board, Dr Hugo Stephenson has agreed to join the company to lead Opin, the company's clinical trial recruitment business. In this role, Dr Stephenson will specifically focus on: Accelerating recruitment for ANZ-based clinical trials and health programs; Streamlining Opin's business model to align with ANZ client needs; Unlocking new business opportunities in patient community growth and management; Broadening Asia Pacific partnerships with research sites, healthcare institutions and advocacy groups; Pursuing M&A opportunities in the Asia Pacific region; and Cultivating global growth opportunities. For the near term, Mr. Mark Ziirsen, Executive Chair will assume expanded executive duties, spending more time in the Melbourne head office, to provide support for these management changes.
Board Change • Jun 28No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 6 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Member of Advisory Board Kirsten Daru is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
Board Change • Jun 05No independent directorsThere are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 6 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Member of Advisory Board Kirsten Daru is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.
공시 • May 04Opyl Limited Appoints Dr. Hugo Stephenson as Board AdvisorOpyl Limited announced that it has engaged leading global clinical trial expert and eminent business leader in the health technology sector, Dr. Hugo Stephenson, as an advisor to the board. His appointment is an important development in the Company's strategic review, which focuses on accelerating the growth of Opin and monetising the TrialKey technology platform. Dr. Stephenson is a medical doctor, technologist, biotech services entrepreneur and founder of a number of successful businesses in the international clinical trials industry, including: DrugDev, a leading provider of e-clinical technologies and clinical trial payment services; MediGuard, the largest online medication monitoring service; Health Research Solutions (HRS), a late phase contract research organisation; and MedSeed, a pioneer of hospital and GP decision support software. Dr. Stephenson worked for many years as the founder of Quintiles' global late phase research division (now IQVIA) following the acquisition of HRS, and has considerable experience managing organisations within both a public market and private equity-backed environment. He is also the founder and past Chief Executive Officer of the Induction Healthcare Group PLC.
Board Change • May 02No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Megan Robertson was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.